Blocking Smallpox: A Second Defense

See allHide authors and affiliations

Science  19 Oct 2001:
Vol. 294, Issue 5542, pp. 500
DOI: 10.1126/science.294.5542.500

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution


Variola, the virus that causes smallpox, was destined for obliteration 6 years ago when a select group of researchers took a new interest in it. The team extensively studied a promising antiviral treatment for variola infection that might be useful in containing an outbreak. They also demonstrated for the first time that the virus can cause fulminant disease in a species other than humans. But their work has been controversial, in part because it raises a question about the World Health Organization plan to destroy all known stocks of variola.